Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Stopping Cyclosporine A led to hair regrowth in a child with alopecia.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Cyclosporine improved skin condition in dogs with sebaceous adenitis.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

A woman developed thick gums from everolimus treatment after a kidney transplant.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Treatments for melanin disorders exist, but more effective options needed.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.